$BCBP
BCB BANCORP INC

2024 Q2 Form 10-Q Financial Statement

#000122845424000006 Filed on May 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $49.29M
YoY Change 16.37%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $438.0K $457.0K
YoY Change -9.88% -4.39%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $26.14M
YoY Change 75.67%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $3.980M $8.326M
YoY Change -66.97% -26.52%
Income Tax $1.163M $2.460M
% Of Pretax Income 29.22% 29.55%
Net Earnings $2.369M $5.432M
YoY Change -71.9% -31.53%
Net Earnings / Revenue 11.02%
Basic Earnings Per Share $0.32
Diluted Earnings Per Share $0.14 $0.32
COMMON SHARES
Basic Shares Outstanding 16.96M 16.96M
Diluted Shares Outstanding 16.94M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $352.4M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $25.90M $24.93M
YoY Change -4.84% -1.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $9.001M $9.223M
YoY Change -29.82% -36.21%
Other Assets $17.23M $17.56M
YoY Change 4.76% 15.66%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $3.794B $3.849B
YoY Change -2.04% 2.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $13.97M $12.58M
YoY Change -0.21% -18.51%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.97M $12.58M
YoY Change -0.21% -18.51%
LONG-TERM LIABILITIES
Long-Term Debt $37.62M $37.62M
YoY Change 0.0% 0.15%
Other Long-Term Liabilities $13.29M $14.25M
YoY Change -0.44% 11.11%
Total Long-Term Liabilities $50.91M $51.88M
YoY Change -0.12% 2.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.97M $12.58M
Total Long-Term Liabilities $50.91M $51.88M
Total Liabilities $3.473B $3.529B
YoY Change -2.8% 1.84%
SHAREHOLDERS EQUITY
Retained Earnings $138.6M
YoY Change 12.61%
Common Stock $199.7M
YoY Change 1.28%
Preferred Stock $27.73M
YoY Change 32.04%
Treasury Stock (at cost) $38.35M
YoY Change 3.39%
Treasury Stock Shares
Shareholders Equity $320.7M $320.1M
YoY Change
Total Liabilities & Shareholders Equity $3.794B $3.849B
YoY Change -2.04% 2.29%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $2.369M $5.432M
YoY Change -71.9% -31.53%
Depreciation, Depletion And Amortization $438.0K $457.0K
YoY Change -9.88% -4.39%
Cash From Operating Activities $8.127M $8.288M
YoY Change 0.22% -49.51%
INVESTING ACTIVITIES
Capital Expenditures $40.00K $144.0K
YoY Change -98.99% 89.47%
Acquisitions
YoY Change
Other Investing Activities $25.00M $52.05M
YoY Change -125.87% -128.04%
Cash From Investing Activities $24.96M $51.91M
YoY Change -124.82% -127.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -58.67M 12.73M
YoY Change -156.08% -93.67%
NET CHANGE
Cash From Operating Activities 8.127M 8.288M
Cash From Investing Activities 24.96M 51.91M
Cash From Financing Activities -58.67M 12.73M
Net Change In Cash -25.58M 72.93M
YoY Change -310.74% 129.93%
FREE CASH FLOW
Cash From Operating Activities $8.127M $8.288M
Capital Expenditures $40.00K $144.0K
Free Cash Flow $8.087M $8.144M
YoY Change 94.03% -50.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Forfeited Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsForfeitedExercisePriceRange
CY2024Q1 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Granted Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsGrantedExercisePriceRange
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001228454
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
CY2023Q1 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
0-50275
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
BCB Bancorp, Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NJ
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-0065262
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
104-110 Avenue C
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Bayonne
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07002
CY2024Q1 dei City Area Code
CityAreaCode
201
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
823-0700
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, no par value
CY2024Q1 dei Trading Symbol
TradingSymbol
BCBP
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16957391
CY2024Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
11795000
CY2023Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
16597000
CY2024Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
340653000
CY2023Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
262926000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
352448000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
279523000
CY2024Q1 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2023Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
86966000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
87769000
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
9223000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
9093000
CY2023Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
1287000
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
34563000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33608000
CY2024Q1 us-gaap Notes Receivable Net
NotesReceivableNet
3226877000
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
3279708000
CY2024Q1 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
24917000
CY2023Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
24917000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12744000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13057000
CY2024Q1 us-gaap Interest Receivable
InterestReceivable
17442000
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
16072000
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
17555000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
18213000
CY2024Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5253000
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5253000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12186000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12935000
CY2024Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
74081000
CY2023Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
73407000
CY2024Q1 us-gaap Other Assets
OtherAssets
8768000
CY2023Q4 us-gaap Other Assets
OtherAssets
10428000
CY2024Q1 us-gaap Assets
Assets
3849195000
CY2023Q4 us-gaap Assets
Assets
3832397000
CY2024Q1 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
531112000
CY2023Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
536264000
CY2024Q1 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
2460547000
CY2023Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
2442816000
CY2024Q1 us-gaap Deposits
Deposits
2991659000
CY2023Q4 us-gaap Deposits
Deposits
2979080000
CY2024Q1 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
472949000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
472811000
CY2024Q1 us-gaap Subordinated Debt
SubordinatedDebt
37624000
CY2023Q4 us-gaap Subordinated Debt
SubordinatedDebt
37624000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
12579000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13315000
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
14253000
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
15512000
CY2024Q1 us-gaap Liabilities
Liabilities
3529064000
CY2023Q4 us-gaap Liabilities
Liabilities
3518342000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2797
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2797
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2528
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2528
CY2024Q1 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
27733000
CY2023Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
25043000
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20191362
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20138294
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16957391
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16904323
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
199726000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
198923000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
138643000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
135927000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7624000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7491000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3233971
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3233971
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
38347000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
38347000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
320131000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
314055000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3849195000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3832397000
CY2024Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
43722000
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
38889000
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
26321000
CY2024Q1 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
305000
CY2023Q1 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
186000
CY2022Q1 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
159000
CY2024Q1 us-gaap Interest Income Other
InterestIncomeOther
975000
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
1120000
CY2022Q1 us-gaap Interest Income Other
InterestIncomeOther
948000
CY2024Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
4283000
CY2023Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
2157000
CY2022Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
296000
CY2024Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
49285000
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
42352000
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
27724000
CY2024Q1 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
5257000
CY2023Q1 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
3154000
CY2022Q1 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
758000
CY2024Q1 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
166000
CY2023Q1 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
118000
CY2022Q1 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
108000
CY2024Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
14983000
CY2023Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
6453000
CY2022Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
980000
CY2024Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
20406000
CY2023Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
9725000
CY2022Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1846000
CY2024Q1 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
5736000
CY2023Q1 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
5156000
CY2022Q1 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
806000
CY2024Q1 us-gaap Interest Expense
InterestExpense
26142000
CY2023Q1 us-gaap Interest Expense
InterestExpense
14881000
CY2022Q1 us-gaap Interest Expense
InterestExpense
2652000
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
23143000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
27471000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
25072000
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
2088000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
622000
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
-2575000
CY2024Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
21055000
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
26849000
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
27647000
CY2024Q1 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
1215000
CY2023Q1 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
1098000
CY2022Q1 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
1214000
CY2024Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
675000
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
421000
CY2022Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
755000
CY2024Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
45000
CY2023Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
6000
CY2022Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
65000
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
4000
CY2024Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
130000
CY2023Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-3227000
CY2022Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2685000
CY2024Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
40000
CY2023Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
38000
CY2022Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
51000
CY2024Q1 us-gaap Noninterest Income
NoninterestIncome
2109000
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
-1664000
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
-600000
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6981000
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
7618000
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6736000
CY2024Q1 us-gaap Occupancy Net
OccupancyNet
2644000
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
2552000
CY2022Q1 us-gaap Occupancy Net
OccupancyNet
2695000
CY2024Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1853000
CY2023Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1665000
CY2022Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1465000
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
595000
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
566000
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
494000
CY2024Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
277000
CY2023Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
265000
CY2022Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
321000
CY2024Q1 bcbp Regulatory Assessments
RegulatoryAssessments
1142000
CY2023Q1 bcbp Regulatory Assessments
RegulatoryAssessments
536000
CY2022Q1 bcbp Regulatory Assessments
RegulatoryAssessments
304000
CY2024Q1 us-gaap Advertising Expense
AdvertisingExpense
216000
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
278000
CY2022Q1 us-gaap Advertising Expense
AdvertisingExpense
141000
CY2023Q1 bcbp Other Real Estate Owned Net
OtherRealEstateOwnedNet
1000
CY2022Q1 bcbp Other Real Estate Owned Net
OtherRealEstateOwnedNet
1000
CY2024Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1130000
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
373000
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
802000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5733000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7984000
CY2024Q1 us-gaap Noninterest Expense
NoninterestExpense
14838000
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
13854000
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
12959000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8326000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11331000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14088000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2460000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3225000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4136000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
5866000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
8106000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
9952000
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
434000
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
173000
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
276000
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5432000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7933000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9676000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16930000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16949000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16980000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16939000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17208000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17343000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
5866000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
8106000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
9952000
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-177000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
13000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-3195000
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-44000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
135000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-792000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-133000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-122000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2403000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7549000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
314055000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
5866000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-133000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2690000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
195000
CY2024Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
434000
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2608000
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
500000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
320131000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
291254000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
8106000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-122000
CY2023Q1 bcbp Stock Issued During Period Shares Stock Option Exercised Excluding Cashless Exercises
StockIssuedDuringPeriodSharesStockOptionExercisedExcludingCashlessExercises
61000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
418000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
106000
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
151753
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2559000
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
173000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2687000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
405000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
297618000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
274024000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
9952000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2403000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
95000
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
515
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8000
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
276000
CY2022Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
5330000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2620000
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2601000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
86000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
276159000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
5866000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
8106000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
9952000
CY2024Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
457000
CY2023Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
478000
CY2022Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
629000
CY2024Q1 bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
-530000
CY2023Q1 bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
-474000
CY2022Q1 bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
-375000
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
2088000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
622000
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
-2575000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
702000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1149000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
735000
CY2024Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
1264000
CY2022Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
2452000
CY2024Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
2596000
CY2023Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
664000
CY2022Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
3144000
CY2024Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
45000
CY2023Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
6000
CY2022Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
65000
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
4000
CY2024Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
130000
CY2023Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-3227000
CY2022Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2685000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
195000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
106000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
95000
CY2024Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
675000
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
421000
CY2022Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
755000
CY2024Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1370000
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1262000
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
410000
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1661000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1100000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
107000
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-127000
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1304000
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-497000
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1132000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1821000
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1748000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8288000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16414000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11752000
CY2024Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
624000
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
4661000
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
3068000
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
7488000
CY2022Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1233000
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4000
CY2024Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-51426000
CY2023Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
183527000
CY2022Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
87723000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
144000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
76000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38000
CY2023Q1 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
6762000
CY2022Q1 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
44000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
51910000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-185704000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-90992000
CY2024Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
12579000
CY2023Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
55602000
CY2022Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
69773000
CY2023Q1 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
50000000
CY2023Q1 bcbp Proceeds From Federal Home Loan Bank Borrowings Short Term Net
ProceedsFromFederalHomeLoanBankBorrowingsShortTermNet
100000000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2559000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8000
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2608000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2687000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2601000
CY2024Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
434000
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
173000
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
276000
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
500000
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
405000
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
86000
CY2024Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
2690000
CY2022Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
2620000
CY2022Q1 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
5330000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
418000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12727000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
201006000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64264000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
72925000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
31716000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14976000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
279523000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
229359000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
411629000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
352448000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
14.60
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
61500
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
16.27
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
261075000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
396653000
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
979000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
797000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
411000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
26268000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
13578000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
3150000
CY2024Q1 bcbp Number Of Locations
NumberOfLocations
28
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 us-gaap Reclassifications
Reclassifications
<span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 3 – Reclassification </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Certain amounts have been reclassified to conform to the current period’s presentation. These changes had no effect on the Company’s results of operations or financial position.</span></p>
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
86752
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.98
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
20625
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
15.75
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
1725
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
14.92
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
64402
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.73
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
48150
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.83
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
27000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.99
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
13650
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
9676000
CY2024Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
156000
CY2023Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
73000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
642000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y18D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
975975
CY2023 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
10.55
CY2023 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.68
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.89
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
80000
CY2024Q1 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Expired Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsExpiredExercisePriceRange
13.32
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
13.32
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
895975
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.76
CY2024Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
39000
CY2023Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
33000
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
508000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5432000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7933000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9676000
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5432000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16930000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7933000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16949000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9676000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16980000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
9000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
259000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
363000
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
5432000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16939000
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
7933000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17208000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2024Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3265145000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3317402000
CY2024Q1 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
3705000
CY2023Q4 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
4086000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17343000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
130000
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-3227000
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-2626000
CY2022Q1 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-59000
CY2024Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
130000
CY2023Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-3227000
CY2022Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2685000
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
96523000
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
89000
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
9646000
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
86966000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
97149000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
192000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
9572000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
87769000
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
5187000
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
209000
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
73573000
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
9437000
CY2024Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
78760000
CY2024Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
9646000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
5316000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
98000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
74009000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
9474000
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
79325000
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
9572000
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
34563000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33608000
CY2024Q1 us-gaap Notes Receivable Net
NotesReceivableNet
3226877000
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
3279708000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33608000
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1151000
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
18000
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
2088000
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
34563000
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
5516000
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
29047000
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
34563000
CY2024Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
65731000
CY2024Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3199414000
CY2024Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3265145000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
32373000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
53000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
622000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
28882000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
2586000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
26296000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
28882000
CY2023Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
17584000
CY2023Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3248387000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3265971000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
32373000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
805000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
101000
CY2023 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
6104000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33608000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
4229000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
29379000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33608000
CY2023Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
54019000
CY2023Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3263383000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3317402000
CY2023Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
694000
CY2024Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
65000
CY2024Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
759000
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
-577000
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
689000
CY2024Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3265145000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3317402000
CY2024Q1 bcbp Financing Receivable Non Accrual With Allowance
FinancingReceivableNonAccrualWithAllowance
6263000
CY2024Q1 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
15978000
CY2024Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
22241000
CY2023Q4 bcbp Financing Receivable Non Accrual With Allowance
FinancingReceivableNonAccrualWithAllowance
6940000
CY2023Q4 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
11843000
CY2023Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
18783000
CY2024Q1 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
710000
CY2023 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
1900000
CY2024Q1 bcbp Loans And Leases Receivable Loans Returned To Accrual Interest Income
LoansAndLeasesReceivableLoansReturnedToAccrualInterestIncome
123000
CY2023 bcbp Loans And Leases Receivable Loans Returned To Accrual Interest Income
LoansAndLeasesReceivableLoansReturnedToAccrualInterestIncome
314000
CY2023Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2024Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2024Q1 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
2259000
CY2024Q1 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
277413000
CY2024Q1 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
940962000
CY2024Q1 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
324375000
CY2024Q1 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
273344000
CY2024Q1 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
1065220000
CY2024Q1 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
378663000
CY2024Q1 us-gaap Financing Receivable Revolving Converted To Term Loan
FinancingReceivableRevolvingConvertedToTermLoan
2909000
CY2024Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3265145000
CY2024Q1 bcbp Financing Receivable Originated Five Or More Years Before Latest Fiscal Year.Charge Offs
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear.ChargeOffs
29000
CY2024Q1 us-gaap Financing Receivable Revolving Writeoff
FinancingReceivableRevolvingWriteoff
1122000
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1151000
CY2023Q4 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
280851000
CY2023Q4 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
959372000
CY2023Q4 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
333030000
CY2023Q4 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
276923000
CY2023Q4 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
72067000
CY2023Q4 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
1021468000
CY2023Q4 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
372776000
CY2023Q4 us-gaap Financing Receivable Revolving Converted To Term Loan
FinancingReceivableRevolvingConvertedToTermLoan
915000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3317402000
CY2023 us-gaap Financing Receivable Revolving Writeoff
FinancingReceivableRevolvingWriteoff
805000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
805000
CY2024Q1 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
74100000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q1 bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2024Q1 bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2018Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
33500000
CY2024Q1 bcbp Lessee Operating Leases Number
LesseeOperatingLeasesNumber
25
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
885000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
936000
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
282000
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
268000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12186000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12935000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2263000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3094000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11526000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11526000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1210000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1305000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
12579000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
13315000
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M17D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y9M7D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0303
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0302
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2263000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3094000
CY2024Q1 bcbp Lessee Operating Lease Liability Payments Year One To Year Three
LesseeOperatingLeaseLiabilityPaymentsYearOneToYearThree
5132000
CY2023Q4 bcbp Lessee Operating Lease Liability Payments Year One To Year Three
LesseeOperatingLeaseLiabilityPaymentsYearOneToYearThree
5132000
CY2024Q1 bcbp Lessee Operating Lease Liability Payments Year Three To Year Five
LesseeOperatingLeaseLiabilityPaymentsYearThreeToYearFive
3632000
CY2023Q4 bcbp Lessee Operating Lease Liability Payments Year Three To Year Five
LesseeOperatingLeaseLiabilityPaymentsYearThreeToYearFive
3632000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2762000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2762000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13789000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14620000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1210000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1305000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
12579000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13315000

Files In Submission

Name View Source Status
0001228454-24-000006-index-headers.html Edgar Link pending
0001228454-24-000006-index.html Edgar Link pending
0001228454-24-000006.txt Edgar Link pending
0001228454-24-000006-xbrl.zip Edgar Link pending
bcbp-20240331.xsd Edgar Link pending
bcbp-20240331x10q.htm Edgar Link pending
bcbp-20240331xex31_1.htm Edgar Link pending
bcbp-20240331xex31_2.htm Edgar Link pending
bcbp-20240331xex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
bcbp-20240331_def.xml Edgar Link unprocessable
bcbp-20240331_lab.xml Edgar Link unprocessable
bcbp-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bcbp-20240331x10q_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bcbp-20240331_cal.xml Edgar Link unprocessable